Add to a list

Inactive Instrument

LOTUS PHARM Stock OTC Bulletin Board

LTUS

US5457151042

Pharmaceuticals

OTC Markets Traded

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE

Lotus Pharmaceuticals Inc is a company mainly engaged in development, manufacture, and sales of pharmaceuticals. The Company produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The Company's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The Company operated in two business segment Wholesales segment and Retail segment. The Company's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The Company mainly conducts its businesses in the domestic market and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	9.74M 8.54M 7.87M 7.37M 13.81M 918M 14.1M 94.57M 36.59M 454M 36.56M 35.76M 1.57B	P/E 2009	3.88x	P/E 2010	4.84x
Enterprise Value	14.38M 12.61M 11.62M 10.88M 20.41M 1.36B 20.83M 140M 54.06M 671M 54.01M 52.83M 2.33B	EV / Sales 2009	1.02x	EV / Sales 2010	0.95x
Free-Float	99%	Yield 2009 *	-	Yield 2010	-

23-07-31	Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries	MT
21-11-26	Thai oil firm PTT expands pharma business with $475 million Alvogen deal	RE
21-09-28	Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund	RE
12-05-16	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS from LTUSE	CI
12-04-19	Lotus Pharmaceuticals, Inc. has Changed its Ticker to LTUS.E from LTUS	CI

12-30	Lotus Pharmaceutical Supports Street Medicine Program to Expand Access to Care for Those Most in Need	AQ
25-10-06	Lotus Enters License and Supply Agreement with Adalvo for Semaglutide injection	AQ
25-08-12	Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales	AQ
25-02-21	Lotus announces FDA acceptance of Potential First-to-File ANDA Submission for Voclosporin soft gelatin capsules, a generic equivalent to Lupkynis	AQ
24-11-08	Lotus Achieves Second-Highest Quarterly Performance in Company History with 3Q24 Financial Results	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.62%	+1.33%	+10.38%	+82.31%	47.38B
OTSUKA HOLDINGS CO., LTD.	+1.02%	+3.06%	+52.92%	+106.87%	35.48B
CIPLA LIMITED	+0.15%	+6.53%	-4.15%	+42.60%	12.33B
ZYDUS LIFESCIENCES LIMITED	+0.19%	+2.86%	+12.18%	+89.10%	11.65B
KRKA, D. D.	-0.57%	+0.38%	+36.72%	+126.29%	8.88B
GEDEON RICHTER	+0.99%	+4.52%	+21.27%	+44.41%	7.21B
ONO PHARMACEUTICAL CO., LTD.	+1.16%	+2.54%	+54.27%	-8.69%	6.91B
GLENMARK PHARMACEUTICALS LIMITED	-1.20%	-2.67%	+25.90%	+218.89%	6.45B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-3.83%	-0.76%	-35.52%	-3.58%	4.94B
Average	-0.30%	+2.62%	+19.33%	+77.58%	15.69B
Weighted average by Cap.	-0.04%	+2.86%	+23.41%	+85.18%

	2009	2010
Net sales	57.82M 50.7M 46.73M 43.75M 82.04M 5.45B 83.75M 562M 217M 2.7B 217M 212M 9.35B	72.7M 63.74M 58.75M 55.01M 103M 6.86B 105M 706M 273M 3.39B 273M 267M 11.75B
Net income	16.43M 14.41M 13.28M 12.43M 23.31M 1.55B 23.8M 160M 61.77M 766M 61.7M 60.36M 2.66B	14.42M 12.65M 11.66M 10.91M 20.47M 1.36B 20.89M 140M 54.22M 673M 54.17M 52.98M 2.33B
Net Debt	5.29 4.64 4.28 4.01 7.51 499.38 7.67 51.42 19.9 246.81 19.88 19.44 855.82	4.65 4.07 3.76 3.52 6.59 438.34 6.73 45.14 17.47 216.64 17.45 17.07 751.2

LOTUS PHARM Stock OTC Bulletin Board

Stocks

LTUS

US5457151042

Pharmaceuticals

Valuation: LOTUS PHARM

Latest news : LOTUS PHARM

Press Releases: LOTUS PHARM

Managers and Directors: LOTUS PHARM

Generic Pharmaceuticals

Financials

Company Profile